Κατευθυντήριες Οδηγίες
-
Κατεβάστε σε μορφή pdf τις Αναθεωρημένες Κατευθυντήριες Οδηγίες της Ευρωπαικής Εταιρίας Υπέρτασης - 2009. -
American Heart Association Learn and Live 2009 STEMI and PCI Focused Update
The TRial Of Preventing HYpertension (TROPHY)
TROPHY - hypothesis
The TRial Of Preventing HYpertension (TROPHY) is an investigator-initiated trial to examine whether early treatment of high-normal blood pressure values (according to JNC VI) with candesartan would prevent or postpone the development of stage 1 hypertension.
TROPHY - objectives
Primary:
- to determine whether treatment with candesartan 16 mg compared with placebo reduces the incidence of hypertension in subjects with high-normal BP
Secondary:
- evaluate reduction of BP after 2 years of treatment with candesartan 16 mg versus placebo
- evaluate incidence of hypertension after 2 years of treatment with candesartan 16 mg versus placebo
- evaluate quality of life during 2 years of treatment with candesartan 16 mg versus placebo
Κατεβάστε την πλήρη παρουσίαση σε μορφή διαφανειών Powerpoint.


